CD4 and COVID-19: Such analysis carried out in this study, has shown that the percentage of both CD38+ HLA-DR+ CD4+ and CD8+ T cell subpopulations is significantly higher in the peripheral blood of COVID-19 patients, compared to HS and VS control groups (Figure 2C).